HEADER LIPID BINDING PROTEIN 07-JUL-11 2LFO TITLE NMR STRUCTURE OF CL-BABP/SS COMPLEXED WITH GLYCOCHENODEOXYCHOLIC AND TITLE 2 GLYCOCHOLIC ACIDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: FATTY ACID-BINDING PROTEIN, LIVER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FATTY ACID-BINDING PROTEIN 1, LIVER BASIC FABP, LB-FABP, COMPND 5 LIVER BILE ACID-BINDING PROTEIN, L-BABP, LIVER-TYPE FATTY ACID- COMPND 6 BINDING PROTEIN, L-FABP; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: BANTAM,CHICKENS; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: FABP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET24D KEYWDS HETEROTYPIC COMPLEX, BILE ACID BINDING PROTEIN, LIVER, BILE ACIDS, KEYWDS 2 LIPID BINDING PROTEIN, DISULPHIDE BRIDGE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.TOMASELLI,C.COGLIATI,K.PAGANO,L.ZETTA,S.ZANZONI,M.ASSFALG, AUTHOR 2 H.MOLINARI,L.RAGONA REVDAT 2 14-JUN-23 2LFO 1 REMARK REVDAT 1 11-JUL-12 2LFO 0 JRNL AUTH S.TOMASELLI,M.ASSFALG,K.PAGANO,C.COGLIATI,S.ZANZONI, JRNL AUTH 2 H.MOLINARI,L.RAGONA JRNL TITL A DISULFIDE BRIDGE ALLOWS FOR SITE-SELECTIVE BINDING IN JRNL TITL 2 LIVER BILE ACID BINDING PROTEIN THEREBY STABILISING THE JRNL TITL 3 ORIENTATION OF KEY AMINO ACID SIDE CHAINS. JRNL REF CHEMISTRY V. 18 2857 2012 JRNL REFN ISSN 0947-6539 JRNL PMID 22298334 JRNL DOI 10.1002/CHEM.201102203 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.26, HADDOCK 2.1 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X-PLOR REMARK 3 NIH), ALEXANDRE BONVIN (HADDOCK) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT IN EXPLICIT SOLVENT REMARK 4 REMARK 4 2LFO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000102334. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.2 REMARK 210 IONIC STRENGTH : 30 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-99% 13C; U-99% 15N] REMARK 210 PROTEIN, 0.5 MM REMARK 210 GLYCOCHENODEOXYCHOLIC ACID, 0.75 REMARK 210 MM GLYCOCHOLIC ACID, 90% H2O/10% REMARK 210 D2O; 0.5 MM [U-99% 13C; U-99% REMARK 210 15N] PROTEIN, 0.5 MM REMARK 210 GLYCOCHENODEOXYCHOLIC ACID, 0.75 REMARK 210 MM GLYCOCHOLIC ACID, 100% D2O; REMARK 210 0.5 MM [U-99% 15N] PROTEIN, 0.5 REMARK 210 MM GLYCOCHENODEOXYCHOLIC ACID, REMARK 210 0.75 MM GLYCOCHOLIC ACID, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D CBCA(CO)NH; REMARK 210 3D HNCACB; 3D HNCO; 3D HCCH- REMARK 210 TOCSY; 3D 1H-15N NOESY; 3D 1H- REMARK 210 13C NOESY ALIPHATIC; 3D 1H-13C REMARK 210 NOESY AROMATIC; 3D F1-[13C]- REMARK 210 FILTERED, F2-[13C]-SEPARATED, F3- REMARK 210 [15N,13C]-EDITED NOESY-HSQC; F1/ REMARK 210 F2-[15N,13C]-FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : BEST HADDOCK SCORE REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 109 HH11 ARG A 120 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 13 47.71 25.82 REMARK 500 1 GLN A 56 140.88 -171.25 REMARK 500 2 GLN A 11 39.63 -155.75 REMARK 500 2 ASN A 13 41.63 37.75 REMARK 500 2 LYS A 43 73.25 -150.91 REMARK 500 2 PRO A 54 37.46 -77.32 REMARK 500 2 ARG A 55 -50.26 -159.51 REMARK 500 2 SER A 93 -159.10 -105.27 REMARK 500 3 GLN A 11 37.79 -140.12 REMARK 500 3 ASN A 13 43.74 39.67 REMARK 500 3 SER A 93 -163.47 -105.14 REMARK 500 4 ALA A 10 159.06 177.49 REMARK 500 4 GLN A 11 40.88 -141.59 REMARK 500 4 ASN A 13 53.56 26.63 REMARK 500 4 TYR A 14 -62.81 -100.97 REMARK 500 4 LYS A 43 76.16 -150.74 REMARK 500 4 PRO A 54 -6.67 -59.70 REMARK 500 4 ARG A 55 -65.96 -108.81 REMARK 500 4 LEU A 64 109.51 -56.29 REMARK 500 5 SER A 3 104.65 -54.23 REMARK 500 5 ALA A 10 133.53 177.12 REMARK 500 5 GLN A 11 59.67 -112.38 REMARK 500 5 GLU A 12 -145.11 -100.46 REMARK 500 5 ASN A 13 31.35 -73.07 REMARK 500 5 GLN A 42 -165.83 -123.86 REMARK 500 5 LYS A 43 90.14 -176.71 REMARK 500 5 ARG A 55 -65.69 -92.53 REMARK 500 5 LEU A 64 108.73 -58.91 REMARK 500 5 SER A 93 -163.64 -104.00 REMARK 500 6 TYR A 9 27.10 -149.19 REMARK 500 6 GLU A 12 -86.18 -70.40 REMARK 500 7 ASN A 13 58.39 15.57 REMARK 500 7 TYR A 14 -61.17 -104.19 REMARK 500 7 PRO A 54 1.31 -68.69 REMARK 500 7 ARG A 55 -61.00 -121.09 REMARK 500 7 CYS A 91 79.94 -118.23 REMARK 500 7 SER A 93 -161.20 -116.92 REMARK 500 8 GLU A 12 -151.41 -105.20 REMARK 500 8 ASN A 13 38.06 -69.08 REMARK 500 8 LYS A 43 81.77 -152.74 REMARK 500 8 GLN A 56 144.65 -172.51 REMARK 500 9 GLN A 11 24.76 -147.37 REMARK 500 9 ASN A 13 49.99 20.97 REMARK 500 9 TYR A 14 -61.36 -94.47 REMARK 500 9 PRO A 54 27.65 -76.35 REMARK 500 9 ARG A 55 -59.56 -146.52 REMARK 500 9 SER A 93 -169.20 -112.30 REMARK 500 10 SER A 3 103.95 -58.07 REMARK 500 10 GLU A 12 -143.58 -85.65 REMARK 500 10 TYR A 14 -62.18 -94.29 REMARK 500 REMARK 500 THIS ENTRY HAS 115 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GCH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHO A 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JN3 RELATED DB: PDB REMARK 900 ENTRY CONTAINING COORDINATES OF CL-BABP COMPLEXED WITH REMARK 900 CHENODEOXYCHOLIC ACID REMARK 900 RELATED ID: 17767 RELATED DB: BMRB DBREF 2LFO A 1 125 UNP P80226 FABPL_CHICK 2 126 SEQADV 2LFO CYS A 91 UNP P80226 THR 92 VARIANT SEQRES 1 A 125 ALA PHE SER GLY THR TRP GLN VAL TYR ALA GLN GLU ASN SEQRES 2 A 125 TYR GLU GLU PHE LEU LYS ALA LEU ALA LEU PRO GLU ASP SEQRES 3 A 125 LEU ILE LYS MET ALA ARG ASP ILE LYS PRO ILE VAL GLU SEQRES 4 A 125 ILE GLN GLN LYS GLY ASP ASP PHE VAL VAL THR SER LYS SEQRES 5 A 125 THR PRO ARG GLN THR VAL THR ASN SER PHE THR LEU GLY SEQRES 6 A 125 LYS GLU ALA ASP ILE THR THR MET ASP GLY LYS LYS LEU SEQRES 7 A 125 LYS CYS THR VAL HIS LEU ALA ASN GLY LYS LEU VAL CYS SEQRES 8 A 125 LYS SER GLU LYS PHE SER HIS GLU GLN GLU VAL LYS GLY SEQRES 9 A 125 ASN GLU MET VAL GLU THR ILE THR PHE GLY GLY VAL THR SEQRES 10 A 125 LEU ILE ARG ARG SER LYS ARG VAL HET GCH A 201 33 HET CHO A 202 32 HETNAM GCH GLYCOCHOLIC ACID HETNAM CHO GLYCOCHENODEOXYCHOLIC ACID HETSYN GCH N-CHOLYLGLYCINE FORMUL 2 GCH C26 H43 N O6 FORMUL 3 CHO C26 H43 N O5 HELIX 1 1 ASN A 13 LEU A 21 1 9 HELIX 2 2 ASP A 26 ARG A 32 1 7 SHEET 1 A10 VAL A 58 THR A 63 0 SHEET 2 A10 ASP A 46 SER A 51 -1 N VAL A 49 O ASN A 60 SHEET 3 A10 ILE A 37 LYS A 43 -1 N GLN A 41 O VAL A 48 SHEET 4 A10 GLY A 4 GLU A 12 -1 N TRP A 6 O VAL A 38 SHEET 5 A10 VAL A 116 ARG A 124 -1 O LYS A 123 N GLN A 7 SHEET 6 A10 GLU A 106 PHE A 113 -1 N MET A 107 O SER A 122 SHEET 7 A10 SER A 97 LYS A 103 -1 N LYS A 103 O GLU A 106 SHEET 8 A10 LYS A 88 LYS A 92 -1 N LEU A 89 O GLN A 100 SHEET 9 A10 LYS A 77 ALA A 85 -1 N HIS A 83 O VAL A 90 SHEET 10 A10 LYS A 66 THR A 71 -1 N ILE A 70 O LEU A 78 SSBOND 1 CYS A 80 CYS A 91 1555 1555 2.03 SITE 1 AC1 11 LEU A 21 VAL A 49 ASN A 60 THR A 72 SITE 2 AC1 11 ASP A 74 LYS A 76 LEU A 78 CYS A 91 SITE 3 AC1 11 HIS A 98 GLN A 100 PHE A 113 SITE 1 AC2 11 TYR A 14 PHE A 17 LEU A 18 LEU A 21 SITE 2 AC2 11 LEU A 27 MET A 30 ALA A 31 ILE A 34 SITE 3 AC2 11 PRO A 54 LEU A 118 ARG A 120 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1